Intrauterine synechiae means thin bands or sheets of scar tissue that stick parts of the uterine cavity together. These scars form after injury or infection of the uterine lining (endometrium). They can partially block or completely close the cavity, which may lead to light periods (hypomenorrhea), absent periods (amenorrhea), pelvic pain, infertility, or pregnancy loss. Doctors also call this condition intrauterine adhesions (IUA) or Asherman syndrome when symptoms are present. The gold-standard way to diagnose and treat it is hysteroscopy—a tiny camera placed through the cervix to look inside the uterus and gently cut the scar tissue. Preventing recurrence often needs barriers (like a balloon or gel) and short courses of hormones to help the lining heal smoothly. NCBI+2PubMed+2
The endometrium has two layers. Superficial cells shed each month, while a deeper “basal” layer regenerates the lining. When trauma (for example, dilation and curettage after a miscarriage) or infection damages that basal layer, opposing uterine walls can heal together, forming bridges of fibrous tissue (adhesions). Mild adhesions may involve only small areas; severe disease can obliterate much of the cavity and even block the openings of the fallopian tubes. These scars disrupt normal shedding and regrowth, and they also reduce blood flow and receptivity for embryo implantation. That’s why periods can be light or absent and why infertility or recurrent pregnancy loss can occur. PMC+1
Intrauterine synechiae are bands of scar tissue that form inside the uterus (and sometimes the cervical canal). These adhesions stick the front and back walls of the uterus together—partly or completely—so the uterine cavity becomes smaller or irregular. The condition is usually acquired after procedures or infections that injure the endometrium (the lining of the uterus). Typical problems include light or absent periods, pelvic pain during periods, infertility, and pregnancy complications. The condition is often called Asherman syndrome when these adhesions cause symptoms such as menstrual change, pain, or difficulty becoming or staying pregnant. The most accurate test is hysteroscopy, a tiny camera placed through the cervix to look directly inside the uterus. Mayo Clinic+3NCBI+3PMC+3
Other names
This condition appears in medical writing under several names that all mean nearly the same thing: Asherman syndrome, intrauterine adhesions (IUA), intrauterine synechiae, and sometimes endometrial adhesions. Using any of these terms will usually point to the same problem—scar bands inside the uterine cavity that can affect periods and fertility. NCBI+1
Types
Doctors describe intrauterine synechiae by thickness, extent, and where they are located.
By thickness. Filmy adhesions are thin, web-like bands that may separate easily at hysteroscopy. Dense/fibrous adhesions are thick, tough, and can partially or completely block the cavity. Dense bands are more likely to cause symptoms and are harder to treat. PMC
By extent. Some people have focal (small, localized) bands; others have extensive adhesions that involve most of the cavity; the most severe cases cause near-complete or complete obliteration of the cavity. Greater extent usually correlates with worse symptoms and lower fertility, and many grading systems reflect this. PMC
By location. Adhesions may occur in the fundus (top of the uterus), along the side walls, across the isthmus, or in the endocervical canal (cervix). Cervical adhesions can lead to stenosis (narrowing) and trapped menstrual blood (hematometra), which causes cyclic pain. Location matters because it influences both symptoms and how surgery is planned. PMC
Causes
Dilatation and curettage (D&C) after miscarriage—especially when done soon after pregnancy—can strip or injure the basal layer of the endometrium and trigger scarring. Risk rises with repeated procedures. PMC
Postpartum curettage for retained placenta or heavy bleeding also increases risk because the fresh postpartum lining is more vulnerable to injury. PMC
Hysteroscopic myomectomy (removal of fibroids inside the cavity) can expose raw surfaces that scar together during healing. Surgeons try to reduce this risk with careful technique. PMC
Hysteroscopic septum resection (cutting a uterine septum) may create opposing raw areas that can adhere if not protected during recovery. PMC
Endometrial ablation (procedure to reduce heavy bleeding) purposely destroys the lining and can lead to cavity obliteration or bands afterward. PMC
Myomectomy that opens the cavity (via laparoscopy or laparotomy) can expose endometrium and cause internal scarring. PMC
Cesarean delivery–related cavity entry is less common as a sole cause, but combined surgical factors or infection can contribute to adhesion formation. PMC
Uterine infections (endometritis) after pregnancy—especially retained tissue with infection—can injure the basal layer and lead to scarring. PMC
Genital tuberculosis (TB endometritis) can damage the lining and cause severe, dense adhesions; this remains an important cause in regions where TB is endemic. NCBI
Schistosomiasis (in endemic areas) has been linked to intrauterine scarring through chronic inflammation. NCBI
Instrumentation in the early postpartum period (e.g., manual cavity exploration) can injure a fragile lining and encourage adhesions. PMC
Retained products of conception with prolonged inflammation can organize into scar bands if not removed and treated promptly. PMC
Uterine artery embolization (for fibroids) rarely may be followed by intrauterine adhesions due to localized endometrial ischemia. PMC
Radiation therapy to the pelvis can thin and scar the endometrium, leading to synechiae. PMC
Intrauterine foreign bodies (e.g., long-retained devices or packing) with associated inflammation are uncommon but reported contributors. PMC
Compression sutures for postpartum hemorrhage (e.g., B-Lynch) can sometimes distort the cavity and, with healing, be associated with adhesions. PMC
Severe endometritis after STI is a less frequent pathway but can damage the basal layer enough to scar. PMC
Multiple uterine surgeries over time (cumulative trauma) increase overall risk compared with a single procedure. PMC
Aggressive curettage in a thin or atrophic endometrium (e.g., in lactation) raises the chance of basal layer injury and scarring. PMC
Idiopathic cases (no clear trigger) are uncommon; when found, careful review often uncovers a prior event or infection that explains the scarring. PMC
Common symptoms and problems
1) Lighter periods (hypomenorrhea). Many people notice their periods become unusually light because scar tissue reduces the surface area of the lining that can grow and shed. PMC
2) No periods (secondary amenorrhea). If adhesions seal much of the cavity or the cervix, menstrual flow may stop entirely, even though hormones cycle normally. PMC
3) Cyclic pelvic pain. When blood cannot exit due to cavity obstruction or cervical adhesions, pressure builds and causes cramping with each cycle. Mayo Clinic
4) Infertility. Adhesions can block sperm passage, prevent implantation, or disrupt the endometrium’s receptivity, making it harder to get pregnant. PMC
5) Recurrent miscarriage. Irregular cavity shape and poor lining can impair normal placental attachment, increasing pregnancy loss risk. PMC
6) Recurrent implantation failure in IVF. An abnormal cavity and damaged functional layer reduce the chance of embryos attaching. PMC
7) Abnormal spotting or brown discharge. Trapped blood or small areas of shedding around adhesions can cause intermittent spotting. PMC
8) Painful periods after previously normal cycles. New-onset dysmenorrhea may reflect partial outflow blockage. Mayo Clinic
9) Difficulty during procedures. Doctors may encounter a “short” or resistant cavity during uterine sounding or embryo transfer because adhesions alter the canal’s path. PMC
10) Cervical stenosis. Adhesions at the cervix can narrow or seal it, leading to outflow problems and procedural difficulty. PMC
11) Hematometra. If the outflow is blocked, blood may collect inside the uterus, causing pain and sometimes a palpable, tender uterus. PMC
12) Obstetric complications in achieved pregnancies. There is higher risk of abnormal placentation (e.g., placenta accreta spectrum), preterm birth, and retained placenta. PMC
13) Pain with intercourse is not typical of adhesions themselves, but may occur if there is coexisting inflammation or other pelvic issues; adhesions mainly affect the cavity rather than the vagina. PMC
14) Anxiety and distress. Menstrual changes and fertility worries often cause understandable emotional stress and reduced quality of life. Support and counseling help. Mayo Clinic
15) Sometimes no symptoms. Mild, filmy adhesions can be “silent” and only found during fertility evaluation or imaging for another reason. PMC
Diagnostic tests
Important note about “electrodiagnostic” tests:
There are no standard electrodiagnostic tests (like nerve or heart conduction tests) for intrauterine synechiae. Diagnosis relies on endoscopic visualization and imaging. In this section, you’ll see the tests that are actually used in practice. PMC
A) Physical examination (what the clinician can see or feel)
General and pelvic exam. Most patients have a normal external and bimanual exam. Sometimes the uterus is tender or slightly enlarged if blood is trapped (hematometra). A normal exam does not rule out adhesions; this is why imaging or hysteroscopy is needed. PMC
Speculum inspection of the cervix. The clinician checks for cervical stenosis or scarring that might explain outflow problems, and to plan safe access for further tests. PMC
B) Manual/office procedures
Uterine sounding. A thin, sterile probe is gently passed to measure the depth and direction of the cavity. In adhesions, the instrument may meet resistance or deviate from the usual path, suggesting internal bands or narrowing. This is a screening clue, not a definitive test. PMC
Office hysteroscopy (diagnostic). A very small camera is passed through the cervix under saline flow to directly see adhesions. This is the gold standard because it gives a real-time, magnified view, allows precise mapping of thickness and extent, and can transition to treatment in the same setting. PMC+1
Cervical dilation assessment. Gentle dilation with small rods (Hegar dilators) may reveal a narrowed or scarred cervix; this helps plan hysteroscopy and warns of outflow blockage. PMC
C) Laboratory and pathology tests (to rule out other causes or triggers)
Pregnancy test. Always done if periods are late or absent, because pregnancy (including ectopic pregnancy) must be excluded before invasive procedures. Adhesions do not cause a positive test; this is about safety and differential diagnosis. PMC
Hormone profile (TSH, prolactin, FSH/LH, estradiol). These tests help rule out endocrine causes of absent or light periods (thyroid disease, hyperprolactinemia, ovarian insufficiency). If hormones are normal but flow is absent, a structural cause like adhesions becomes more likely. PMC
Infection testing (endometritis screen). If there is a history of postpartum infection or retained tissue, clinicians may test and treat infection; controlling inflammation reduces further damage before hysteroscopic treatment. PMC
Tuberculosis evaluation (when epidemiology suggests risk). This may include endometrial sampling for AFB, culture, PCR, or referral to TB specialists. TB-related adhesions are often dense and extensive. NCBI
Endometrial biopsy (selected cases). Histology may show fibrosis and inactive or atrophic glands; the main value is to exclude other causes of bleeding problems rather than to “prove” adhesions. PMC
D) Imaging tests (pictures of the cavity)
Transvaginal ultrasound (TVUS). This is usually the first imaging test. It may show a thin endometrium, irregular cavity, or bands, but sensitivity is limited. A normal ultrasound does not exclude adhesions. PMC
Saline infusion sonohysterography (SIS). Sterile saline is infused through the cervix during ultrasound to outline the cavity. Adhesions appear as bridging bands that restrict fluid spread. SIS is more informative than standard ultrasound for mapping adhesions. PMC
3D ultrasound. Three-dimensional reconstructions improve visualization of where adhesions tether the walls. This helps grade severity and plan surgery. PMC
Hysterosalpingography (HSG). Dye is injected through the cervix while X-rays are taken. Adhesions show as linear or triangular filling defects and irregular cavity outlines. HSG can also show tubal patency, which is useful in infertility workups. Radiopaedia+1
MRI (selected situations). MRI is not routine but may help when the cavity is nearly obliterated, anatomy is unclear, or other diagnoses (e.g., congenital anomalies) must be considered before surgery. PMC
Combined SIS + HSG information. Using both can clarify cavity shape and tubal status before hysteroscopy, especially in complex infertility cases or after prior surgeries. PMC
E) Endoscopic confirmation (the definitive method)
Diagnostic hysteroscopy (again, the gold standard). This test directly confirms the diagnosis, allows gentle probing of bands, and records thickness/extent. It also identifies normal landmarks (tubal ostia, fundus) to guide safe adhesiolysis. PMC+1
Operative hysteroscopy with adhesiolysis (therapeutic test). During the same session, filmy bands can be separated with the hysteroscope tip or small scissors; dense bands may need careful cutting with cold instruments or energy under direct vision. Successful restoration of a normal cavity confirms the functional significance of the adhesions. PMC+1
F) Tests that help assess impact and outcomes
Fertility assessment (e.g., ovulation tracking or IVF planning). After cavity restoration, clinicians track return of menses and endometrial growth to judge whether the lining functions again. This is not a diagnosis test by itself but measures recovery. PMC
Follow-up hysteroscopy or imaging. Because adhesions can recur—especially after severe disease—repeat office hysteroscopy or a targeted SIS/3D ultrasound may be scheduled to confirm the cavity stays open. PMC
Non-pharmacological treatments (therapies & others)
(Each described briefly; evidence centers on hysteroscopic lysis plus measures to prevent recurrence.)
Diagnostic & therapeutic hysteroscopy (adhesiolysis): Gentle, direct cutting of scars with scissors/energy to restore cavity shape; cornerstone of care for symptomatic IUAs. Purpose: restore menstruation and fertility; Mechanism: physically separates fused walls. jmig.org+1
Ultrasound-guided hysteroscopy: Adds real-time imaging for safety in severe disease; Mechanism: reduces risk of perforation, helps find true cavity. jmig.org
Second-look hysteroscopy (early): 1–8 weeks after surgery to lyse new filmy bands before they mature; lowers recurrence. jmig.org
Mechanical barrier—Foley balloon: A soft catheter balloon left a few days keeps walls apart to prevent re-adhesion. Mechanism: physical separation while the lining re-epithelializes. jmig.org
Mechanical barrier—IUD (inert): Occasionally used as a spacer; benefit is less consistent than balloons/gels. jmig.org
Viscous adhesion-prevention gel (e.g., hyaluronic-acid gel): Coats raw surfaces to reduce scar formation; network meta-analyses suggest lower recurrence vs no barrier. ScienceDirect
Avoid repeat curettage when possible: Prefer ultrasound-guided evacuation or medical management to minimize fresh basal-layer injury. jmig.org
Treat uterine infection before/after procedures: Reduces inflammatory scarring triggers. jmig.org
Gentle cervical dilation techniques: Minimize mechanical trauma during entry. jmig.org
Fertility counseling & timing: Try conception after lining recovery and cavity confirmation; IVF may be needed if other factors exist. PubMed
Lifestyle optimization (weight, smoking cessation): Supports endometrial receptivity and pregnancy outcomes. PMC
Menstrual tracking & symptom diary: Helps detect recurrence (cycles getting lighter again). NCBI
Psychological support/counseling: Chronic infertility/pregnancy loss is stressful; counseling improves adherence and coping. PMC
Shared decision-making using guideline summaries: Ensures realistic expectations, especially with severe IUAs. jmig.org
Expectant management for mild IUAs in some cases: Recent data suggest no live-birth benefit from surgery in mild disease; careful selection required. BioMed Central
Use of small-caliber hysteroscopes & minimal energy: Less trauma → less new scarring. jmig.org
Office hysteroscopy for minor filmy bands: Reduces anesthesia risks and may speed recovery. ScienceDirect
Pelvic pain management strategies (heat, gentle activity): Symptom relief while awaiting treatment; does not treat adhesions themselves. NCBI
Early postpartum/post-miscarriage ultrasound follow-up if heavy intervention was needed: Detects retained tissue and guides safer, ultrasound-guided evacuation rather than blind curettage. jmig.org
Specialist referral to centers with IUA experience: Complex cases have better outcomes with experienced teams and protocols for recurrence prevention. jmig.org
Drug treatments
(Medications support healing or treat associated problems; they do not “melt” dense scars. Doses are typical examples—always individualized by a clinician.)
Estrogen therapy (e.g., estradiol 2–6 mg/day orally for 2–4 weeks, then add progestin 10–14 days): Purpose: promote endometrial regrowth after adhesiolysis; Mechanism: proliferative stimulus; Side effects: breast tenderness, nausea, VTE risk in high-risk patients. jmig.org
Combined estrogen–progestin cycles (e.g., OCPs for 1–2 cycles): Purpose: structured cycling during early healing; Side effects: nausea, mood change, rare VTE. jmig.org
Progesterone challenge (e.g., medroxyprogesterone 10 mg/day ×10 days): Purpose: test bleeding response, support organized shedding; Side effects: bloating, mood change. NCBI
Antibiotics (tailored; e.g., doxycycline if endometritis suspected): Purpose: treat infection before/after surgery; Side effects: GI upset, photosensitivity (drug-specific). jmig.org
NSAIDs (e.g., ibuprofen 400–600 mg q6–8h PRN): Purpose: pain control post-procedure; Side effects: dyspepsia, renal risk in susceptible patients. NCBI
Topical/instilled hyaluronic-acid gel (device/agent): Though not a “drug” in the classic sense, it’s placed intrauterine at surgery to prevent recurrence; minimal systemic effects. ScienceDirect
Antibiotic prophylaxis (single peri-operative dose per local protocol): Purpose: lower infection risk. jmig.org
Gentle cervical-ripening agents (e.g., misoprostol per protocol): Purpose: reduce mechanical trauma entry; Side effects: cramping, diarrhea. jmig.org
Tranexamic acid (short course) if heavy bleeding post-lysis: Purpose: antifibrinolytic hemostasis; Side effects: nausea; thrombosis risk in predisposed. jmig.org
GnRH agonist (selected complex cases): Purpose: temporarily quiet endometrium before staged reconstruction; Side effects: hot flashes, bone loss with long use. (Specialist use; evidence limited.) jmig.org
Low-dose aspirin (selected IVF contexts): Purpose: theoretical perfusion benefit; Evidence is mixed; use individualized. Side effects: gastritis, bleeding. PubMed
Vaginal estrogen cream (e.g., 0.5–1 g/day for 2–4 weeks): Purpose: support local healing at the cervical canal in cervical adhesions. jmig.org
Antibiotic therapy for genital TB (RIPE regimen per ID specialist): When TB endometritis is confirmed. Side effects depend on agents (e.g., hepatotoxicity). NCBI
Antiparasitic treatment for schistosomiasis (praziquantel) when indicated. NCBI
Progestin-only therapy for withdrawal bleeding attempts (if estrogen contraindicated). NCBI
Iron supplementation if anemic from abnormal bleeding (typical 45–65 mg elemental iron/day). NCBI
Antimicrobial coverage for chronic endometritis (culture-guided) before fertility attempts. ScienceDirect
Analgesic ladder including acetaminophen for pain control to avoid excessive NSAIDs. NCBI
Short course of antibiotics when a balloon is left in situ (per local protocol) to reduce infection risk; evidence varies. jmig.org
Peri-operative vasopressin (surgeon-administered, dilute) to lower bleeding and improve visualization; specialized use. jmig.org
Important: Medication choices, doses, and durations are individualized by your gynecologist; some interventions (e.g., gels, balloons) are treated as devices rather than drugs. jmig.org
Dietary “molecular” supplements (supportive, not curative)
(These do not dissolve adhesions; they support general reproductive health when appropriate. Discuss with your clinician—evidence varies.)
Iron (if deficient): Restores hemoglobin and energy; typical 45–65 mg elemental/day; mechanism: replaces iron lost with bleeding. NCBI
Folic acid (400–800 µg/day) when trying to conceive: Reduces neural-tube defects; supports cell proliferation. PMC
Vitamin D (dose per level, often 1000–2000 IU/day): Low levels are common in infertility; supports immune modulation and endometrial function. PMC
Omega-3 fatty acids (e.g., 1 g/day EPA/DHA): Anti-inflammatory support; may aid general reproductive health. PMC
CoQ10 (100–200 mg/day): Antioxidant; sometimes used in infertility care; evidence mixed. PMC
Vitamin B12 (if low): Corrects deficiency that can affect general health and pregnancy outcomes. PMC
Iodine (150 µg/day in prenatal multivitamin): Supports thyroid; thyroid health affects cycles/fertility. PMC
Zinc (8–12 mg/day in diet/supplement): Supports cell growth/repair; excess can cause copper deficiency. PMC
Selenium (55–100 µg/day; avoid high doses): Antioxidant; overuse can be harmful. PMC
Prenatal multivitamin (with iron/folate/iodine): Practical one-pill coverage while planning pregnancy. PMC
Immunity-booster / regenerative / stem-cell” drugs (perspective)
(These ideas are experimental or not standard of care for IUAs; I’m listing them because you asked, with caution.)
Experimental stem-cell therapy (e.g., bone-marrow–derived cells): Investigational for endometrial regeneration; dosing/protocols vary; mechanism: attempt to repopulate endometrium. Not standard care. ScienceDirect
Platelet-rich plasma (PRP) intrauterine infusion: Emerging adjunct after adhesiolysis; proposed growth-factor support; protocols vary; evidence evolving. ScienceDirect
Granulocyte colony-stimulating factor (G-CSF) intrauterine use: Studied off-label for thin endometrium; mixed data. ScienceDirect
Low-dose aspirin (systemic): Theoretical micro-perfusion support; evidence inconsistent. PubMed
Pentoxifylline + Vitamin E: Studied in endometrial injury/fibrosis with mixed results; off-label. ScienceDirect
Hyaluronic-acid–based gels (device): Best-supported “regenerative”-adjacent measure is actually mechanical/biophysical barrier to reduce new scar formation, not an immune drug. ScienceDirect
Surgeries (what is done and why)
Hysteroscopic adhesiolysis with scissors: Precise, mechanical cutting under direct vision to restore cavity; why: mainstay for symptomatic IUAs (pain, infertility, RPL). jmig.org
Hysteroscopic adhesiolysis with energy (bipolar): For thicker bands; why: easier hemostasis; used carefully to avoid new thermal injury. jmig.org
Ultrasound-guided adhesiolysis in severe/obliterated cavities: why: improves safety and helps find the true cavity. jmig.org
Staged reconstruction with early second-look: why: severe scarring often needs more than one session; early re-lysis prevents maturation of new bands. jmig.org
Adjunct barrier placement at the end of surgery (balloon/gel): why: lowers recurrence by keeping walls apart during healing. ScienceDirect
Preventions
Prefer ultrasound-guided evacuation over blind curettage when possible.
Use gentle technique and minimal instrumentation in all intrauterine procedures.
Avoid unnecessary repeat curettage; consider medical management for miscarriage where appropriate.
Treat infections promptly (pre/post-procedure).
Use barriers (balloon/gel) in high-risk hysteroscopic cases.
Limit thermal energy in the cavity to what’s necessary.
Follow-up after high-risk procedures to detect and treat early filmy adhesions.
Counsel on risks and signs (lighter/absent periods) after procedures.
Optimize anemia and nutrition to support healing.
Refer complex cases to experienced centers. jmig.org+1
When to see a doctor (red flags)
Periods become much lighter or stop after a miscarriage, postpartum curettage, or uterine surgery.
Pelvic pain with little/no menstrual flow.
Trouble conceiving after a uterine procedure.
Recurrent miscarriages.
Fever, foul discharge, or severe cramps after any intrauterine procedure.
Prompt evaluation can confirm the diagnosis and plan safe treatment. NCBI
What to eat and what to avoid (simple, supportive)
Eat more: iron-rich foods (lean meats, beans, leafy greens), folate sources (greens, legumes), vitamin-D sources, calcium, iodine (iodized salt), whole grains, fruits, vegetables, and omega-3-rich fish (where safe). Why: supports recovery from anemia and general reproductive health. Avoid/limit: smoking, heavy alcohol, excessive caffeine, highly processed foods high in sugar/salt, and self-medicating with unproven supplements. Food choices don’t dissolve adhesions, but they help overall health and pregnancy readiness alongside medical care. PMC
Frequently asked questions
Are intrauterine synechiae and Asherman syndrome the same?
They refer to the same problem (adhesions). “Asherman syndrome” is often used when symptoms like infertility or absent periods are present. NCBICan adhesions go away on their own?
Filmy, mild adhesions sometimes separate during diagnostic procedures, but dense scars usually need hysteroscopic lysis. jmig.orgWhat is the best test?
Hysteroscopy is the gold standard because the doctor can see and treat in the same setting. SIS and HSG are useful screening tools. ScienceDirectWill surgery restore my periods?
Many regain normal or improved flow after successful lysis, especially in mild-to-moderate disease. Results depend on severity. jmig.orgWill I be able to get pregnant afterward?
Pregnancy rates improve after adhesiolysis, particularly outside the most severe cases, though exact success varies by severity and other factors. PubMedDo all mild cases need surgery?
Not always. A 2025 study found no live-birth benefit of surgery vs expectant care in mild IUAs—decision should be individualized. BioMed CentralHow do doctors prevent adhesions from coming back?
Mechanical separation (balloon/gel), short-term hormones, gentle technique, and early second-look hysteroscopy. ScienceDirect+1Are anti-adhesion gels safe?
Hyaluronic-acid–based gels are well-tolerated and reduce recurrence in trials; your surgeon will choose what fits your case. ScienceDirectDo I need antibiotics?
Often a single peri-operative dose is used per protocol; full courses are for proven or suspected infection. jmig.orgCan an IUD be used as a spacer?
Sometimes, but balloons/gels have stronger evidence for reducing recurrence. ScienceDirectIs endometrial ablation a risk?
Yes. It can lead to scarring that complicates future evaluation and fertility. RCOGHow soon can I try to conceive after treatment?
After healing is confirmed (often after one or more cycles and/or second-look hysteroscopy), per your doctor’s plan. jmig.orgIs IVF always required?
Not always. Some conceive naturally after cavity restoration; IVF helps when other infertility factors exist. PubMedWhat if I have recurrent adhesions?
A staged approach with repeat lysis and rigorous prevention measures is used in expert centers. jmig.orgWhere can I read trusted guidance?
AAGL/ESGE practice guidelines and high-quality reviews are good starting points. PubMed+1
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: September 24, 2025.
